Endometriosis Trial, Recruiting (NCT06414720)

Endometriosis Trial, Recruiting NCT06414720 Sponsor: University of Udine Condition: Endometriosis

Printed from Voxsanity (voxsanity.com.au) — NCT06414720 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Endometriosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be over 18 years old
You must be of childbearing age (able to have children)
You must have been diagnosed with endometriosis, either through ultrasound/clinical assessment or through a tissue biopsy
You must be willing to give your informed consent to take part in the study

Who may not be able to join:

You cannot join if you are currently pregnant
You cannot join if you have not yet started your periods, or if you have gone through menopause
You cannot join if you have been diagnosed with chronic pelvic pain syndrome, with or without a condition called central sensitization (confirm with trial site)
You cannot join if you have cancer, diabetes, a body mass index (BMI) over 30, blood clotting disorders, autoimmune diseases, or any other conditions that could affect a specific type of saliva test used in this study (confirm with trial site)
You cannot join if you are currently taking a type of hormone medication called progestins

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Giuseppe Vizzielli, prof, University of Udine

Phone: 3206173076

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06414720

Sponsor: University of Udine

Phase: Not Applicable

Status: Recruiting

Condition: Endometriosis

Trial contact: 3206173076

More information: https://clinicaltrials.gov/study/NCT06414720

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be over 18 years old
You must be of childbearing age (able to have children)
You must have been diagnosed with endometriosis, either through ultrasound/clinical assessment or through a tissue biopsy
You must be willing to give your informed consent to take part in the study

Who may not be able to join:

You cannot join if you are currently pregnant
You cannot join if you have not yet started your periods, or if you have gone through menopause
You cannot join if you have been diagnosed with chronic pelvic pain syndrome, with or without a condition called central sensitization (confirm with trial site)
You cannot join if you have cancer, diabetes, a body mass index (BMI) over 30, blood clotting disorders, autoimmune diseases, or any other conditions that could affect a specific type of saliva test used in this study (confirm with trial site)
You cannot join if you are currently taking a type of hormone medication called progestins

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Udine

Registry

ClinicalTrials.gov

Start date

22 April 2024

Est. completion

1 December 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

response to the progestin therapy; changes in quality of life; differences in salivary miRNoma

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov